4//SEC Filing
Donnelly Brian J 4
Accession 0002065630-25-000004
CIK 0000899923other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:15 PM ET
Size
9.2 KB
Accession
0002065630-25-000004
Insider Transaction Report
Form 4
Donnelly Brian J
Chief Commerical Officer
Transactions
- Award
Common Stock
2025-05-01+269,905→ 269,905 total - Award
Common Stock
2025-05-01+127,629→ 397,534 total - Award
Performance-Based Restricted Stock Units
2025-05-01+236,167→ 236,167 total→ Common Stock (236,167 underlying)
Footnotes (3)
- [F1]Consists of time-based restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.
- [F2]Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.
- [F3]The shares subject to the performance-based restricted stock units ("PSUs") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than May 1, 2026.
Documents
Issuer
MYRIAD GENETICS INC
CIK 0000899923
Entity typeother
Related Parties
1- filerCIK 0002065630
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:15 PM ET
- Size
- 9.2 KB